Presentations

Documents

Order by : Name | Date | Hits [ Ascendant ]

Novel Biomarkers and Technologies to Assess Fibrosis and Remodeling in NASH Novel Biomarkers and Technologies to Assess Fibrosis and Remodeling in NASH

hot!
Date added: 04/11/2019
Date modified: 04/11/2019
Filesize: 256 Bytes
Downloads: 1064

Oral presentation given by UMC at AASLD/EASL NAFLD Endpoints Conference, Alexandria, VA, USA, 30th June 2018

Defining a Clinically Meaningful Change in Circulating Biomarker, Imaging and Elastography Based... Defining a Clinically Meaningful Change in Circulating Biomarker, Imaging and Elastography Based...

hot!
Date added: 04/11/2019
Date modified: 04/11/2019
Filesize: 256 Bytes
Downloads: 1058

"Defining a Clinically Meaningful Change in Circulating Biomarker, Imaging and Elastography Based Assessment of Pre-cirrhotic NASH"

Invited presentation given by UNITO at AASLD/EASL NAFLD Endpoints Conference, Alexandria, VA, USA, 30th June 2018

Lean Subjects with Fatty Liver Show Decreased GLP-1 and GIP Response during OGTT Lean Subjects with Fatty Liver Show Decreased GLP-1 and GIP Response during OGTT

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 448.62 kB
Downloads: 602

Poster presentation given by CNR at the American Diabetes Association’s 78th Scientific Sessions Conference, Orlando, USA, 22nd - 26th June 2018

Diagnostic tools to assess fibrosis in practice and clinical trials Diagnostic tools to assess fibrosis in practice and clinical trials

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 1136

Oral presentation given by UMC at Digestive Disease Week (DDW), Washington DC, USA, 2nd - 5th June 2018

Metabolomics Metabolomics

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 1128

Oral presentation given by CNR at the International Symposium: “Biomarkers for Personalized Hepatology”, Pisa, Italy, 30th May 2018

The burden of fatty liver disease in an aging population The burden of fatty liver disease in an aging population

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 1076

Oral presentation given by UNITO at the 52nd Annual Scientific Meeting of the European Society for Clinical Investigation (ESCI 2018), Barcelona, Spain, 31st May 2018

Mitochondra and progression of NAFLD Mitochondra and progression of NAFLD

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 1088

Oral presentation given by CNR at the  27th Annual Meeting of the Italian Society for the study of Diabetes (SID), Rimini, Italy, 19th May 2018

Study design to validate biomarkers of therapeutic response in NASH due to cirrhosis Study design to validate biomarkers of therapeutic response in NASH due to cirrhosis

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 1132

Oral presentation given by UMC at the 3rd International Workshop on NASH Biomarkers, Washington DC, USA, 18th - 19th May 2018

Lipidomics workflows in clinical research – practical considerations Lipidomics workflows in clinical research – practical considerations

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 1073

Oral presentation given by ORU at the 42nd International Symposium on Capillary Chromatography (ISCC), Riva del Garda, Italy, 16th May 2018

Prevalence, severity and patterns of clinical practice in outpatient visits for suspected NAFLD... Prevalence, severity and patterns of clinical practice in outpatient visits for suspected NAFLD...

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 513.18 kB
Downloads: 680

"Prevalence, severity and patterns of clinical practice in outpatient visits for suspected NAFLD – the German CONSTANS STUDY"

Poster presentation given by UMCM, UNEW & ICAN at the EASL International Liver Congress, Paris, France, 11th - 15th April 2018